Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pituitary-thyroid function in patients with breast cancer.

R Abe, A Hirosaki, M Kimura

    The Tohoku Journal of Experimental Medicine
    |October 1, 1980
    PubMed
    Summary

    Thyroid function, assessed by radioiodine uptake and thyroxin levels, showed no significant differences in patients with benign breast diseases or breast cancer. Dynamic hormone testing after thyrotrophin-releasing hormone stimulation also revealed no significant variations among disease groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Heparin inhibits the progression phase of subcultured endothelial cell proliferation in rat aorta.

    Japanese journal of pharmacology·1992
    Same author

    Antiproliferative effects of the traditional Chinese medicine shimotsu-to, its component cnidium rhizome and derived compounds on primary cultures of mouse aorta smooth muscle cells.

    Japanese journal of pharmacology·1992
    Same author

    [Quenching of ethidium-DNA fluorescence by novel acridines with antitumor activities].

    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·1992
    Same author

    Comparative study of penetration of lomefloxacin and ceftriaxone into transudative and exudative pleural effusion.

    Antimicrobial agents and chemotherapy·1992
    Same author

    Analysis of the human tyrosine hydroxylase promoter-chloramphenicol acetyltransferase chimeric gene expression in transgenic mice.

    Brain research. Molecular brain research·1992
    Same author

    Clotrimazole-induced modulation of hepatic cytochrome P450 enzymes in Syrian and Chinese hamsters.

    Biochemical pharmacology·1992

    Area of Science:

    • Endocrinology
    • Oncology
    • Reproductive Medicine

    Background:

    • Thyroid dysfunction is common, and its relationship with breast diseases requires further investigation.
    • Previous studies suggest potential links, but findings remain inconclusive.
    • Understanding these connections can aid in diagnosis and treatment strategies for breast conditions.

    Purpose of the Study:

    • To investigate the relationship between thyroid function and breast diseases, including benign conditions and breast cancer.
    • To assess both static thyroid hormone levels and dynamic hormonal responses to thyrotrophin-releasing hormone (TRH) stimulation.
    • To determine if thyroid function differs between patients with benign breast disease, localized breast cancer, and metastasized breast cancer.

    Main Methods:

    Related Experiment Videos

  • Measurements of radioiodine uptake and serum thyroxin (T4) levels were performed.
  • Dynamic testing involved measuring serum thyroid stimulating hormone (TSH), prolactin, tri-iodothyronine (T3), and T4 levels before and after TRH stimulation.
  • Patients were categorized into groups: benign breast disease, localized breast cancer, and metastasized breast cancer.

    • Main Results:

    • No significant differences were observed in mean radioiodine uptake rates or T4 levels among the patient groups.
    • Serum TSH, prolactin, T3, and T4 levels did not show significant variations before or after TRH stimulation across the benign disease, localized cancer, and metastasized cancer groups.
    • These findings indicate that conventional thyroid function tests and dynamic hormonal responses to TRH do not differentiate between benign breast conditions and breast cancer stages.

    Conclusions:

    • Thyroid function, as assessed by standard tests and TRH stimulation, does not appear to be significantly altered in patients with benign breast diseases or breast cancer.
    • The study suggests that thyroid hormones and their dynamic responses to TRH are unlikely to serve as biomarkers for distinguishing between benign breast conditions and breast cancer.
    • Further research may be needed to explore other potential endocrine influences on breast diseases.